Izzatullo Ziyoyiddin o`g`li Abdullaev

Mr. Izzatullo Ziyoyiddin o`g`li Abdullaev

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Biomedical Research
Verified
Journal Article
Open access
PDF file
IAIzzatullo Ziyoyiddin o`g`li Abdullaev
Izzatullo Ziyoyiddin o`g`li Abdullaev
UGUlugbek Gapparjanovich Gayibov
Ulugbek Gapparjanovich Gayibov
SOSirojiddin Zoirovich Omonturdiev
Sirojiddin Zoirovich Omonturdiev
SFSobirova Fotima
Sobirova Fotima
SGSabina Narimanovna Gayibova
Sabina Narimanovna Gayibova
TATakhir Fatikhovich Aripov
Takhir Fatikhovich Aripov
Chronic hypoxia is a key factor in the pathogenesis of cardiovascular diseases, including ischemia, heart failure, and hypertension. Under hypoxic conditions, oxygen deficiency disrupts oxidative phosphorylation in mitochondria, impairing ATP production and generating reactive oxygen species (ROS). These reactive species induce mitochondrial dysfunction, leading to oxidative stress, calcium imbalance, and activation of apoptosis pathways. Mitochondrial K-ATP (mitoK-ATP) and mitochondrial permeability transition pore (mPTP) channels are particularly affected, contributing to membrane potential loss, cytochrome C release, and cell death. This review explores the molecular mechanisms underlying hypoxia-induced cardiovascular diseases, with a focus on mitochondrial impairment, ion channel dysfunction, and ROS overproduction. Additionally, we examine hypoxia-inducible factor 1-alpha (HIF-1α) as a biomarker of cellular adaptation and discuss therapeutic strategies targeting mitochondrial function and oxidative stress. Antioxidants and compounds modulating key ion channels, such as K-ATP and mPTP, are highlighted as promising interventions for mitigating hypoxia-induced damage. Furthermore, we emphasize the potential of integrating in vitro, in vivo, and in silico studies to develop novel therapies aimed at preserving mitochondrial integrity and preventing cardiovascular diseases.

25 June 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
OZOmonturdiev Sirojiddin Zoirovich
Omonturdiev Sirojiddin Zoirovich
IAIzzatullo Ziyoyiddin o`g`li Abdullaev
Izzatullo Ziyoyiddin o`g`li Abdullaev
IRInomjonov Dolimjon Raxmatillayevich
Inomjonov Dolimjon Raxmatillayevich
MUMaxmudov Lazizbek Umarjonovich
Maxmudov Lazizbek Umarjonovich
ZRZaripova Mehrangiz Ravshanovna
Zaripova Mehrangiz Ravshanovna
AFAripov Takhir Fatikhovich
Aripov Takhir Fatikhovich
According to the literature, Ájuga turkestánica extract has an effective impact on diseases of the cardiovascular system. Aortic smooth muscle ion transport systems play an important role in the development of these diseases1. This study investigated the effects of Ájuga turkestánica extract on ion transport systems in rat aortic smooth muscle preparations under isometric conditions in vitro, and it was found that this extract exerts a strong dose-dependent relaxant effect on the contraction induced by KCl (50 mM) From the obtained results, the effect of this extract on potential-dependent Ca2+ channels was estimated, and in order to confirm the assumption, it was compared with verapamil, a specific blocker of this channel, and the effect of Ájuga turkestánica extract on potential-dependent Ca2+ channels was determined. In the course of the studies, it was assumed that the investigated extract affects not only the potential-dependent Ca2+ channels, but also the receptor-dependent Ca2+ channels, the Ca2+ transport system in the sarcoplasmic reticulum, and the endothelium-dependent relaxation mechanisms. According to the results of the study, it was found that Ájuga turkestánica extract has an effective effect on these ion transport systems (the results obtained are described in detail in the article below).

4 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
AAAzizbek A. Azamatov
Azizbek A. Azamatov
FTFiruza Tursunkhodzhaeva
Firuza Tursunkhodzhaeva
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
ZBZufar Boboev
Zufar Boboev
KKKuvonchbek Fakhriddin ugli Kuchimov
Kuvonchbek Fakhriddin ugli Kuchimov
UGUlugbek G. Gayibov
Ulugbek G. Gayibov
Non-steroidal anti-inflammatory drugs (NSAIDs) are used globally for their pain-relieving and fever-reducing properties. However, excessive intake of NSAIDs can have harmful effects on multiple body systems, including the cardiovascular, gastrointestinal, hepatic, renal, and nervous systems. The anti-inflammatory activity of 34 derivatives of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline was investigated in vivo. A relationship between the activity of the compounds and the nature of their substituents, as well as their positional and mutual arrangement in the C ring (1-Ar-), was established. In silico modeling of these 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives’ interaction with the COX-2 (PDB ID: 1PXX) active site revealed that the nitro-derivatives exhibited the highest stability owing to their superior capacity for electrostatic and hydrogen bond formation compared to brominated compounds. These data on the effects of the substituents –NH2, –OH, and –OCH3 in ring C (1-Ar-) of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines on anti-inflammatory activity promote the search for new, highly effective derivatives within this series.

26 November 2025 in Plant Science Today
Verified
Journal Article
Open access
PDF file
GUGayibov Ulugbek
Gayibov Ulugbek
IAIzzatullo Ziyoyiddin o`g`li Abdullaev
Izzatullo Ziyoyiddin o`g`li Abdullaev
SFSobirova Fotima
Sobirova Fotima
OSOmonturdiev Sirojiddin
Omonturdiev Sirojiddin
AAAbdullaev Azizbek
Abdullaev Azizbek
ATAripov Takhir
Aripov Takhir
Antihypoxic drugs are vital for protecting cells from oxygen deprivation in ischemia, stroke and heart failure. Despite their clinical potential, a unified understanding of their mechanisms and optimization strategies remains limited. This review addresses this gap by exploring how these agents interact with mitochondrial and cardiovascular ion channels to preserve cellular viability under hypoxic stress. We focus on their modulation of mitochondrial permeability transition pores (mPTP), ATP-sensitive potassium (K-ATP) channels and calcium flux through L-type and R-type channels, which are central to maintaining mitochondrial integrity and vascular function. Additionally, we examine how these compounds regulate hypoxia-inducible factor 1-alpha (HIF-1α), promote efficient electron transport and sustain redox homeostasis. Key strategies for enhancing therapeutic efficacy such as increasing lipophilicity, introducing conjugated π-systems and modifying functional groups are discussed in relation to membrane permeability and intracellular delivery. Particular emphasis is placed on the physicochemical properties that influence bilayer penetration and target specificity. Overall, this review highlights the structural and functional features that underlie the effectiveness of antihypoxic agents and provides insight into their optimization for improved clinical performance in hypoxia-related pathologies.

25 August 2026 in ChemistrySelect
Verified
Journal Article
Open access
PDF file
MAMuyassar Azimova
Muyassar Azimova
IAIzzatullo Ziyoyiddin o`g`li Abdullaev
Izzatullo Ziyoyiddin o`g`li Abdullaev
SGSabina Gayibova
Sabina Gayibova
MKMiroslava Kačániová
Miroslava Kačániová
EIEva Ivanišová
Eva Ivanišová
ÖAÖmür Acet
Ömür Acet
Inula helenium L. root extract has been investigated for antioxidant and antimicrobial activity; however, its phytochemical profile, antimicrobial effects, membrane interactions, and in vivo protection against oxidative injury have not previously been evaluated within a single framework. This study investigated the phytochemical composition, antioxidant and antimicrobial activities, membrane interactions, and protective effect of ethanolic I. helenium L. root extract against doxorubicin (DOX)‐induced hepatic oxidative stress. Tannins were the predominant phytochemical class (247.72 ± 10.00 µg/g DW), followed by phenolic acids (7.99 ± 0.06 µg/g DW) and sesquiterpene lactones (0.711 ± 0.05 µg/g DW). LC‐MS tentatively identified alantolactone/isoalantolactone (C 15 H 20 O 2 ). The extract showed moderate antioxidant activity and selective antimicrobial effects, with the strongest activity against Candida krusei and Yersinia enterocolitica . Differential scanning calorimetry demonstrated concentration‐dependent fluidization of DPPC lipid bilayers, indicating direct membrane interaction. In vivo, extract administration (200 and 400 mg/kg, p.o.) significantly reduced DOX‐induced hepatic malondialdehyde levels, restoring them to intact‐control values ( p < 0.001), despite moderate in vitro radical‐scavenging activity. Acute toxicity testing showed no mortality at 5000 mg/kg. Overall, I. helenium L. root extract protects against DOX‐induced hepatic oxidative stress through complementary biochemical and membrane‐level mechanisms, supporting its potential for nutraceutical and pharmaceutical applications.

30 September 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
MSMurodil Salaydinov
Murodil Salaydinov
AZAnvar Zaynabiddinov
Anvar Zaynabiddinov
IAIzzatullo Ziyoyiddin o`g`li Abdullaev
Izzatullo Ziyoyiddin o`g`li Abdullaev
UGUlugbek Gayibov
Ulugbek Gayibov
GLGaybullo Lutpillayev
Gaybullo Lutpillayev
GAGafurjan Abdullayev
Gafurjan Abdullayev
Calcium dysregulation plays a critical role in vascular dysfunction and the development of cardiovascular diseases. The present study investigated the relaxant activity of KC-4 and its interaction with calcium transport-associated proteins using integrated in vitro and in silico approaches. Vasorelaxant activity was evaluated in isolated rat aortic rings precontracted with 50 mM KCl or 1 μM phenylephrine. The involvement of calcium transport pathways was further assessed using verapamil and phentolamine. Molecular docking studies were performed against major calcium transport proteins, including Ca²⁺-ATPase, SERCA, NCX1, RyR, and voltage-gated calcium channels. KC-4 produced concentration-dependent relaxation of both KCl- and phenylephrine-induced contractions, with IC₅₀ values of 23.15 μM and 18.21 μM, respectively. The greater inhibition of phenylephrine-induced contraction suggests that KC-4 modulates both voltage-dependent and receptor-operated calcium signaling pathways. Comparative experiments with verapamil and phentolamine further supported the involvement of calcium transport mechanisms in the relaxant activity of KC-4. Molecular docking analysis revealed favorable binding affinities of KC-4 toward Ca²⁺-ATPase (−11.7 kcal/mol), L-type calcium channels (−10.8 kcal/mol), SERCA (−10.2 kcal/mol), and R-type calcium channels (−10.2 kcal/mol), whereas weaker interactions were observed with NCX1 and RyR. These findings indicate that KC-4 may regulate vascular smooth muscle contraction through modulation of multiple calcium transport systems. The combined experimental and computational results identify KC-4 as a promising calcium transport-modulating compound with potential relevance for the development of novel agents targeting vascular disorders.